Altered bioavailability of testosterone in androgen-binding protein-transgenic mice.
Serum and intra-testicular total and free testosterone levels in different age groups of mice (7-360-day-old) were analyzed by radioimmunoassay (RIA) in age-matched wild type (WT)-control and in transgenic mice homozygous to rat androgen-binding protein (ABP-TG), in order to identify possible causes of increased pre-pubertal germ cell apoptosis, spermatogenetic defect and reduced fertility seen in ABP-TG mice. Total intra-testicular testosterone levels in the pre-pubertal ABP-TG (7, 14, 21 and 30-day-old) mice were significantly lower than those in age-matched WT-controls. After puberty (60 days and older) the total intra-testicular testosterone levels were higher than those in age-matched WT-controls and increased gradually, peaking on day 180. Serum total testosterone levels in ABP-TG mice did not differ from those in WT-control until day 30. However, a significant increase in the level of serum total testosterone was observed from day 60. Serum and intra-testicular free testosterone levels were significantly lower in 30, 120, 180 and 360-day-old ABP-TG mice than in age-matched WT-controls. Immunohistochemistry for the cholesterol side-chain cleavage (cytochrome P450) enzyme and quantitative real-time RT-PCR analysis of mRNAs for androgen receptor and for enzymes related to steroidogenesis did not show any changes in 30-day-old ABP-TG mice, indicating that the rates of steroidogenesis and utilization were not altered. Human chorionic gonadotrophin (hCG) administration to adult ABP-TG mice increased the intra-testicular total and free testosterone as well as total germ cell counts. We conclude that the presence of greater than physiological concentration of ABP in the mouse testis alters the ratio of free/bound testosterone, and thereby decreases the availability of free testosterone. As a result, a heightened wave of germ cell apoptosis during the pre-pubertal period followed by a reduction in germ cell numbers and reduced fertility is seen in these mice.
Jeyaraj
D Antony
DA
Department of Cell and Developmental Biology and Laboratories for Reproductive Biology, University of North Carolina, Chapel Hill, NC 27599, USA. antojeya@hotmail.com
Grossman
Gail
G
Petrusz
Peter
P
D000727:Androgen-Binding Protein / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis; D001682:Biological Availability; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D005260:Female; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D011863:Radioimmunoassay; D051381:Rats; D013737:Testis / Q000187:drug effects / Q000378:metabolism; D013739:Testosterone / Q000493:pharmacokinetics*
D000727:Androgen-Binding Protein; D006063:Chorionic Gonadotropin; D013739:Testosterone